top of page


23rd January 2019 All Members Meeting
We had a very informative All Member Meeting on 23rd January with great presentations from both Dr Paul Catchpole, Value & Access...


Cancer52 welcomes NHS Long Term Plan
This is an ambitious plan by NHS England to move more care into the community and out of hospital, accompanied by increased funding for...


A short film of patient voices
As the NHS Long Term Plan is published - some messages of hope from people with rare and less common cancer for 2019 and beyond …. a...
Briefing on the 2019 Voluntary Scheme for Branded Medicines from the Association of the British Phar
Slides from the recent Briefing on the 2019 Voluntary Scheme for Branded Medicines from the Association of the British Pharmaceutical...


Britain Against Cancer conference 2018
It was great to see some of you at the Britain Against Cancer conference on 4 December and thank you to those of you – or your patients -...


What the National Data Opt-out means for cancer patients
Cancer52, together with use MY data, have jointly produced a briefing document on what The National Data Opt-out means for cancer...


Cancer52 in the New Statesman
We are delighted that Cancer52 features in this month's New Statesman's Oncology Supplement, published to coincide with this year's...
Cancer52 Trustee Recruitment
We are pleased to announce that Cancer52 is recruiting trustees to its board to support the future development and growth of the...
Cancer52 film on PHE website
In June, at the PHE Cancer Services, Data and Outcomes Conference 2018, Cancer52 worked with the National Cancer Registration and...


Cancer Registration
When a person is diagnosed with cancer in the UK information about them is automatically included in their national cancer registry. It...
bottom of page
